Document is current
Any future updates will be listed below
-
Authors
Mao, Tiebo
Zhang, Xiaofei
Xu, Haiyan
Zhang, Xiao
Ge, Weiyu
Li, Shumin
Ma, Jingyu
Yue, Ming
Xue, Shengbai
Cui, Jiujie
Wang, Liwei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82171824, 81874048)
Innovation Group Project of Shanghai Municipal Health Commission (2019CXJQ03)
Shanghai Municipal Commission of Health and Family Planning (2018ZHYL0223)
Fostering Fund of Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine (PYIV-17-001)
Shanghai Municipal Commission of Health and Family Planning Grant (2018ZHYL0223)
Clinical Research Plan of SHDC (SHDC2020CR1035B)
Scientific and Technological Innovation Project of Science and Technology Commission of Shanghai Munici-pality (21JC1404300)
Project from CSCO Clinical Oncology Research Foundation (Y-2019AZZD-0513)
- License Information
-
More Information
Article History
Received: 7 October 2022
Accepted: 24 November 2022
First Online: 1 December 2022
Declarations
:
: The research protocol was approved by the ethical committee of Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital; the ethical approval code is KY [2019]035. And the informed consent has been retrieved from the participants. All subjects provided written informed consent. Human PC resection specimens were retrieved from Shanghai Renji Hospital under informed consent from all patients. <i>Informed Consent</i> Informed consent was obtained from all subjects involved in the study.
: The authors declare no conflict of interest.
